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The indiscriminate use of antibiotics has made many microorganisms develop resistance to them. This 
has created immense clinical problems in the treatment of infectious diseases. Therefore, there is a 
need to develop alternative antimicrobial agents for the treatment of infectious diseases. Non-antibiotic 
approaches to the treatment and prevention of infection includes the application of honey and milk. 
Milk naturally contains an array of bioactivities due to lysozyme, lactoferrin, immunoglobulins, growth 
factors, and hormones, which are secreted in their active form by the mammary gland. The combination 
of milk and honey may prove to be important source of nutrition and for protection against microbial 
infection. In this review article we discuss the importance of honey, milk and their combination in 
providing protection from infection.  
 





Antibiotics are molecules that stop microbes (both 
bacteria and fungi) from growing or killing them outright. 
However, antibiotics are sometimes associated with 
adverse effects on host which include hypersensitivity, 
depletion of beneficial gut and mucosal microorganisms, 
immunosuppression and allergic reactions. There is, 
therefore, a need to develop alternative antimicrobial 
agents for the treatment of infectious diseases. There are 
already several non-antibiotic approaches to the treat-
ment and prevention of infection including the use of 
honey. Bovine and human milk have also been reported 
to possess antimicrobial activities. Milk is an established 
and healthy food source for energy, proteins, vitamins, 
and minerals. In addition to its value as a nutrient source, 
interest has arisen in the ability of milk to kill bacteria and 
how this knowledge can be applied to human health. A 
number of proteins like immunoglobulins found in milk 
under various conditions exhibit antimicrobial activity and 
can confer passive immunity from mother to the neonate. 
The young of many mammalian species are not born with 
an effective immune system. The immunoglobulins 
protect the neonate from infection until their own immune 
system is developed. The use of   honey, milk and combi-
nation of both may reduce the indiscriminate use of 
antibiotics.  
In this article, we review our knowledge of the 
antimicrobial effect of honey, milk and combination of 
both. We also discuss our own experience from in vitro 
tests on the benefit of combining milk and honey against 
bacterial infection.  We will start by giving a brief review 
of the antimicrobial activity of honey, then of milk and 
thereafter we will discuss combination of honey with milk 
and with antibiotics.  
 
 
ANTIMICROBIAL ACTIVITY OF HONEY 
 
Honey is acceptable in the medical profession as an 
antibacterial agent for the treatment of some diseases 
and infections resulting from wounds and burns (Zumla 
and Lulat, 1989). In many cases, it is used with success 
on infections not responding to standard antibiotic and 
antiseptic therapy. Its effectiveness as an antibacterial 
agent is widely reported (Molan, 1992b).  Honey is the 
substance made when the nectar and sweet deposits 
from plants are gathered, modified and stored in the 
honeycomb by honey bees. The definition of honey 
depends upon who defines it. Most people think of honey 
as excellent food, but some others consider it an elixir, 
and still others as medicine (Zaghloul et al., 2001).  
Essentially, honey is an invert sugar (a mixture of glucose  
and fructose) dissolved in 14 to 20% water with minor 
amounts of organic acids, along with traces of minerals 





flowering plants which the honey bee collects. Nectar 
consists primarily of 10 to 50% sucrose, glucose, and 
fructose, and 50 to 90% water (Audrey et al., 1995). The 
source of honey determines many of the attributes of 
honey such as aroma, flavor, color and composition.  
Honey has had a valued place in traditional medicine 
for centuries. The anicient Egyptians, Assyrians, 
Chinese, Greeks and Romans employed honey for 
wounds and diseases of the gut. Honey was the most 
popular Egyptian drug being mentioned 500 times in 900 
remedies (Zumla and Lulat, 1989). Whilst Hippocrates 
(3rd and 4th centuries BC) made little use of drugs in 
treatment, he prescribed a simple diet, favoring honey 
given as oxymel (vinegar and honey) for pain, hydromel 
(water and honey) for thirst and a mixture of honey, water 
and various medicinal substances for acute fevers 
(Zumla and Lulat, 1989). During the biblical era honey 
received a religious endorsement by both Islam and 
Christianity.  
  More intensive studies did not commence until the year 
1955 where the word ‘inhibine’ for the antibacterial 
activity of honey was introduced, a term which has been 
widely used since the beginning of literature on honey 
(White and Subers 1963). Since then there have been 
many reports on the antimicrobial activity of honey. Some 
have been of simple testing that has shown honey to 
have antibacterial activities (Molan, 1992a). Most, 
however, have involved investigation of the activity 
spectrum of honey (i.e. determining which species of 
micro-organisms are sensitive to the action of honey), or 
comparison of different types of honey for the potency of 
their action against one or more species of bacteria. Also, 
there have been many investigations of the antibacterial 
substances present in honey (Molan, 1992a).  
The low pH of honey is inhibitory to many animal 
pathogens. Under experimental conditions, especially 
with heavily diluted honeys, the growth medium tends to 
neutralize the acidity of the honey so that it does not 
cause inhibition but when honey is used as a dressing on 
a wound or ulcer, bacteria may be in contact with honey 
that is much less diluted and the acidity could well be of 
importance. The fairly strong buffering capacity of body 
fluids may likely neutralize the acidity of honey in other 
situations where there is greater dilution of honey.  
Hydrogen peroxide, a component of honey is well 
known as an antibacterial agent, although it is mostly 
used as an antiseptic rather than antibacterial agent. It 
has been out of favor with the medical profession since it 
first came into use in the late 19th century (Molan, 2001). 
It has been suggested that it readily decomposes in 
solutions containing traces of catalytic metals such as 
iron or copper. This may be the reason why hydrogen 
peroxide went out of favor as an antiseptic after initially 
being hailed as an antibacterial and cleansing agent 
when first introduced (Turner, 1983). There was an 
upsurge of interest in its use later when stabilized 
preparations  became  available,   with   good   germicidal  




activity being reported (Turner, 1983). But in more recent 
times, it has again gone out of favor as awareness has 
developed of its inflammatory properties and damage 
caused to tissue by its oxygen free radicals (Salahudeen 
et al., 1991; Halliwell and Cross, 1994; Saissy et al., 
1995). However, the hydrogen peroxide concentration 
produced in honey activated by dilution is typically around 
1 mmol/l, about one thousand times the level in the 3% 
solution that is commonly used as an antiseptic (Molan 
and Russel 1988; Molan, 1992b). There is also a 
potential for honey to sequester and inactivate the metal 
ions which catalyse the formation of oxygen radicals from 
hydrogen peroxide, and the antioxidant components of 
honey to mop up any free radicals that may be formed.    
Aristotle, in 350 BC, and Discorides, in AD 50, 
recommended that honey collected in specific regions 
and seasons could be used for the treatment of different 
ailments (Molan, 1992b). This consideration is continued 
into present-day folk medicine. The strawberry-tree 
(Arbutus unedo) is valued for its therapeutic properties, 
while in India lotus (Nulumbium sceiosum) is said to be a 
panacea for eye diseases. In modern clinical practice, 
however, these views have gone unnoticed, though 
laboratory findings have found large differences in the 
antibacterial potency of honey from different floral 
sources.    
In almost all studies in which more than one type of 
honey has been used, differences in the antibacterial 
activity of honey have been observed (Al-Jabri et al., 
2003; Molan, 1992b). The degree of difference observed 
has in some cases been very large and in many others 
very small. The differences are attributable to limited 
range of testing rather than variation in the activity of the 
honeys (Molan, 1992b). 
 
 
THERAPEUTIC PROPERTIES OF HONEY  
 
The antimicrobial activity of honey is very important 
therapeutically, especially in situations where the body’s 
immune response is insufficient to clear infection. 
Bacteria often produce protein-digesting enzymes, which 
can be very destructive to tissues (Church, 1954) and 
can destroy the protein growth factors that are produced 
by the body to stimulate the regeneration of damaged 
tissues in the healing process (Postmes and Vandeputte, 
1999). Furthermore, some bacteria produce toxins that 
kill tissue cells (Davis and Arnold, 1974). Additional 
damage is often caused by bacteria carrying antigens 
that stimulate a prolonged inflammatory immune 
response which give excessive production of free radicals 
that are very damaging to tissues. Bacteria in wounds 
can also consume oxygen, and thus make the level of 
oxygen available in wound tissues drop to a point where 
tissue growth is impaired (Christopher, 2001). The 
consequences of bacterial infection are; non-healing of 
wounds; increase in size of wounds and development  of  
ulcers  and  abscesses;  failure  of   skin grafts; and  




inflammation causing swelling and pain. All these can be 
avoided by administering honey to clear infection. In 
addition to having a direct antibacterial action, honey may 
clear infection through a number of properties including 
boosting the immune system, its anti-inflammatory action, 
its antioxidant activity and stimulation of cell growth.  
It has been reported that honey stimulates T-
lymphocytes in cell culture to multiply, and activates 
neutrophils (Abuharfeil et al., 1999). It has also been 
reported that honey stimulates monocytes in cell cultures 
to release the cytokines TNF-alpha, IL-1 and IL-6, the cell 
‘messengers’ that activate the many facets of the immune 
response to infection (Jones et al., 2000). In addition to 
stimulation of these leucocytes, honey provides a supply 
of glucose, which is essential for the ‘respiratory burst’ in 
macrophages that produce hydrogen peroxide, the 
dominant component of their bacteria-destroying activity 
(Molan, 2001). Furthermore, it provides substrates for 
glycolysis, which is the major mechanism for energy 
production in the macrophages, and thus allows them to 
function in damaged tissue and exudates where the 
oxygen supply is often poor. The acidity of honey may 
also assist in the bacteria-destroying action of 
macrophages, as an acid pH inside the phagocytotic 
vacuole is involved in killing ingested bacteria (Molan, 
2001). 
The anti-inflammatory properties of honey have been 
well established. It has been observed clinically that 
when honey is applied to wound, it visibly reduces 
inflammation (Subrahmanyam, 1998). It has also been 
observed to reduce oedema around wounds 
(Subrahmanyam, 1996; Effem, 1993 and 1988; 
Dumronglert, 1983) and exudates from wounds (Hejase 
et al., 1996), both of which result from inflammation. Pain 
is another feature of inflammation, and honey has been 
observed to be soothing when applied to wounds 
(Subrahmanyam, 1993). A histological study of biopsy 
samples from wounds has also shown that there are 
fewer of the leucocytes associated with inflammation 
present in the wound tissues (Subrahmanyam, 1998). 
What is responsible for these observation is a direct anti-
inflammatory effect, not a secondary effect resulting from 
the antibacterial action removing inflammation-causing 
bacteria. The anti-inflammatory effects of honey have 
been demonstrated in histological studies of wounds in 
animals where there was no infection involved (Gupta et 
al., 1992; Postmes et al., 1997; Oryan and Zaker, 1998). 
The anti-inflammatory action of honey is potentially 
very important therapeutically, as the consequences of 
inflammation can be major. Although inflammation is a 
vital part of the normal response to infection or injury, 
when it is excessive or prolonged it can prevent healing 
or even cause further damage. The anti-inflammatory 
action of honey has been found in a clinical trial to 
prevent  partial-thickness  burns  from  converting  to   full 






The reduction in keloids and scarring that is a feature 
of the dressing of wounds with honey (Subrahmanyam, 
1994; Effem, 1993; Subrahmanyam, 1991), and the 
cosmetically good results obtained (Dunford et al., 2000), 
are probably due to the anti-inflammatory action of 
honey. Thus, there are significant benefits to be derived 
from therapeutic use of anti-inflammatory substances. 
However, the pharmaceutical ones have serious 
limitations: corticosteroids suppress tissue growth and 
suppress the immune response (Molan, 2001), and the 
non-steroidal anti-inflammatory drugs are harmful to cells, 
especially in the stomach. But honey has an anti-
inflammatory action free from adverse side effects.        
It has been observed clinically that when honey is 
used as a wound dressing it promotes rapid healing of 
wounds (Bergman et al., 1983; Blomfield, 1973). It has 
been reported by many clinicians that honey promotes 
the formation of clean healthy granulation tissue (the 
clusters of fibroblasts around new capillary beds that is 
the regenerating connective tissue) (Effem, 1993). It has 
also been reported that honey hastens epithelialization of 
the wound (coverage with a new outer layer of skin), 
making skin grafting unnecessary (Subrahmanyam, 
1998; Hejase et al., 1996; Effem, 1993). It is likely that it 
is the stimulation of cell growth by honey that is 
responsible for ‘kick-starting’ the healing process 
observed in chronic wounds which have remained non-
healing for long periods (Wood et al., 1997; Harris, 1994; 
Somerfield, 1991).    
 
     
HARMLESSNESS OF HONEY 
 
Honey has no adverse effects other than a stinging 
sensation experienced by some people when it is applied 
to open wounds (Wood et al., 1997; Ndayisaba et al., 
1993). A transient stinging sensation and redness of the 
eye soon after applying honey in the eye, but never 
enough to stop the treatment, was reported in the 102 
cases in a trial of honey for opthalmological use (Emarah, 
1982). Over the thousands of years, honey has been 
used on open wounds and in the eyes. It has not gained 
any reputation for adverse effects, and this is borne out 
by histological examination of wound tissues that have 
been treated with honey (Postmes et al., 1997; Gupta et 
al., 1992). In papers describing the application of honey 
to open wounds it is reported to be soothing, to relieve 
pain (Subrahmanyam, 1993), be non-irritating 
(Subrahmanyam, 1996), cause no pain on dressing 
(Mcinerney, 1990), and give no secondary reactions 
(Ndayisaba et al., 1993). Although allergy to antibiotics is 
fairly common, allergy to honey is rare and it may be a 
reaction to either the pollen or the bee proteins in honey 
(Bauer et al., 1996). There is a hypothetical risk of 
infection of wounds resulting from the application of 
honey, as honey sometimes contains viable spores of 
Clostridia (Mossel, 1980). However, in none of the many 





wounds (Molan, 1998) there are no reports of any type of 
infection resulting from the application of honey to 
wounds. Spores germinate of Clostridia, being obligate 
anaerobes, would be unlikely to survive in the presence 
of the hydrogen peroxide that is generated in diluted 
honey. But any concern about risk of infection can be 
overcome by the use of honey that has been treated by 
gamma-irradiation, which kills clostridial spores in honey 
(Molan and Allen 1996) without loss of any of the 
antibacterial activity. 
There is a hypothetical risk of blood glucose levels in 
diabetics being raised through glucose being absorbed 
from honey across the bed of large wounds, but in cases 
where this has been checked there has been no sign of 
this happening (Akhtar and Khan, 1989). Where honey is 
taken by mouth by diabetics for treatment of 
gastrointestinal infections the risk is greater, but research 
has shown that honey gives a lower peak of blood 
glucose than table sugar does because the absorption 
from the gut is slower (Samanta et al., 1985). 
 
 
ANTIMICROBIAL ACTIVITY OF BOVINE MILK  
 
Milk is an established and healthy food source for energy, 
proteins, vitamins, and minerals. In addition to its value 
as a nutrient source, interest has arisen in the ability of 
milk to kill bacteria and how this knowledge can be 
applied to human health. A number of proteins like 
immunoglobulins found in milk under various conditions 
exhibit antimicrobial activity and can confer passive 
immunity from mother to the neonate. The young of many 
mammalian species are not born with an effective 
immune system. The immunoglobulins protect the 
neonate from infection until their own immune system is 
developed. Immunoglobulins are found in high 
concentrations in colostrums, the first milk, and in low 
concentrations in milk.  In addition to the 
immunoglobulins, other proteins found in milk are thought 
to have antimicrobial activities. Four of these proteins are 
lactoferrin, lactoperoxidase, lysozyme and N acetyle-
eta-D-glucosaminidase; (NAGase). 
   Lactoferrin, an iron-binding glycoprotein, was first 
isolated from cow’s milk and subsequently from human 
milk. Lactoferrin is present in large quantities in 
mammalian secretions such as milk, tears, saliva and 
seminal fluid, as well as in some white blood cells. 
Lactoferrin is one of the minor proteins naturally occurring 
in cow’s milk at an average concentration of about 0.2 g/L 
(Kai et al., 2002). In colostrums, the lactoferrin content 
can be as high as 0.5 to 1 g/L. Lactoferrin concentration 
in mammary secretions from dry cows increases until 
about 30 days after drying off. The highest lactoferrin 
concentration found in cow mammary secretions is about 
50 to 100 g/L. In human milk and colostrum, the reported 
concentrations of lactoferrin are 2 to 4 g/L and 6 to  8 g/L,  




respectively. In its natural state, lactoferrin  is  only  partly 
saturated with iron (5 to 30%). Lactoferrin has many 
proposed biological functions, including antibacterial/anti-
inflammatory activities, defense against gastro-intestinal 
infections, participation in local secretory immune 
systems in synergism with some immunoglobulins and 
other protective proteins (Joslin et al., 2002). Other 
functions include provision of iron binding antioxidant 
protein in tissues, and possibly promotion of growth of 
animal cells such as lymphocytes and intestinal cells.  
Most microorganisms need iron for growth and 
lactoferrin has the potential to inhibit the growth of 
bacteria, and even kill them by depriving them of iron. 
The effectiveness of the antibacterial activity of lactoferrin 
depends on the iron requirement of the organism, the 
availability of exogenous iron, and the concentration and 
degree of iron-saturation of lactoferrin (Nagy et al., 1976). 
It has been shown that ‘natural’ lactoferrin is bacterio-
static against a wide range of microorganisms, including 
Gram negative bacteria with high iron requirements 
(coliforms, which are major mastitis pathogens) and also 
against some Gram positive organisms such as 
Staphylococcus aureus (also a major mastitis pathogen), 
Bacillus species, and Listeria monocytogenes. Lactic acid 
bacteria in the stomach and intestine have low iron 
requirements and are generally not affected. 
Diarra et al. (2002) conducted a study to evaluate the 
therapeutic potential of bovine lactoferrin or lactoferricin 
in combination with penicillin G against S. aureus. 
Minimal inhibitory concentrations of lactoferrin, lactoferri-
cin, penicillin, and combinations of lactoferrin or lactoferri-
cin with penicillin were determined for fifteen S. aureus 
strains including several strains resistant to eta-lactam 
antibiotics. The fractional inhibitory concentration index 
indicated a synergistic effect between lactoferrin and 
penicillin. Combination of lactoferrin with penicillin 
increased the inhibitory activity of penicillin by 2 to 4 fold 
and reduced the growth rate of S. aureus strains tested, 
whereas the increase in the inhibitory activity of lactofer-
rin by penicillin was 16 to 64 fold. The addition of iron to 
the medium containing a combination of penicillin and 
lactoferrin had no effect on growth inhibition. Electron 
microscopy revealed that concentrations below the 
minimal inhibitory concentrations of penicillin induced 
important ultra-structure alterations, which were further 
enhanced by the presence of lactoferrin. When S. aureus 
is grown in the presence of a combination of penicillin 
and lactoferrin, changes in the protein profile of the 
bacteria, including the disappearance of several protein 
bands due to the presence of lactoferrin, were observed. 
These data suggested that bovine lactoferrin in 
combination with eta-lactam antibiotics can increase the 
antibacterial activity of these antibiotics against S. aureus 
resistant to antibiotics. 
  Peroxidase enzymes can kill bacteria by oxidative 
mechanisms. Peroxidase activity occurs in various 
exocrine   gland    secretions    including    saliva,    tears,  




bronchial, nasal, and intestinal secretions, as well as milk 
(Duran et al., 2002). Milk peroxide is known as 
lactoperoxidase, which is one of the non immunoglobulin 
protective proteins and a prominent enzyme that plays a 
role in protection against microbial invasion of the 
mammary gland. Each lactoperoxidase molecule 
contains one iron atom. Bovine milk contains 
concentrations of about 0.03 g/L of lactoperoxidase 
(Losnedahl et al., 1996). In bovine colostrum, the 
lactoperoxidase content is very low but increases rapidly 
after 4 to 5 days postpartum. Lactoperoxidase itself has 
no antibacterial activity. However, together with hydrogen 
peroxide and thiocyanate, lactoperoxidase forms a potent 
natural antibacterial system, the so-called 
lactoperoxidase system. Both hydrogen peroxide and 
thiocyanate are naturally distributed in animal and human 
tissues, although they are generally in very low 
concentrations.  
   Lysozyme is an enzyme present in the milk of some 
species, especially human milk. There are two types of 
lysozyme: one type is found in the hen egg-white and is 
known as chicken-type or C-lysozyme and the other type 
is found in the goose egg-white and is known as goose 
type or G-lysozyme. Human lysozymes are considered to 
be the C-lysozyme type. However, cow milk may contain 
both C- and G-lysozymes because both types are found 
in various other body fluids and in the stomach tissue of 
the cow. Lysozyme is believed to kill bacteria by 
distributing the formation of a glycosidic bond between 
the two components of peptidoglycan, a constituent of the 
bacterial cell wall (Losnedahl et al., 1996).  
   Lysozyme activity is nearly undetectable in cow’s milk, 
but very high in human milk (0.12 g/L) (Musser et al., 
2002; Losnedahl et al., 1996). The concentration of 
lysozyme is highest in human colostrum and pre-colostral 
milk. The limited lysozyme activity in cow milk increases 
due to mastitis and high somatic cell counts. Heating cow 
milk at 75°C for 15 minutes destroys 25% percent of the 
activity of this enzyme. However, human milk lysozyme is 
more heat stable than cow milk lysozyme. Lysozyme 
possesses antibacterial activity against a number of 
bacteria. This enzyme usually functions in association 
with lactoferrin or immunoglobulin-A. Lysozyme is 
effective against Escherichia coli in concert with 
immunoglobulin-A. It causes lysis of some species of 
salmonellae in association with ascorbate and peroxide 
both of which are present in low concentrations in milk. 
The enzyme can limit the migration of neutrophils into 
damaged tissue and might function as an anti-
inflammatory agent (Saraswathi et al., 2002).   
 
 
COMBINATIONS OF ANTIBACTERIAL AGENTS 
 
The combination of two or more antibacterial agents has 
been  long  accepted  in  the  treatment   of   tuberculosis, 
which limits the selection of mutants resistant to the 
individual components. The use of eta-lactamase 





streptococcal endocarditis is well established, since the 
mixture is more bactericidal than the individual 
components. A combination of a eta-lactamase 
antibiotic with a eta-lactamase inhibitor may prevent 
destruction of the antibiotic. Thus, the enzyme inhibitor 
clavulanic acid in combination with amoxicillin (co-
amoxiclav) restores the activity of the antibiotic against 
many eta-lactamase-producing bacteria. 
   Potentiation of the antibacterial effect by antibiotics 
combinations is referred to as synergy. Some 
combinations exhibit a lesser effect than the individual 
components and this is called antagonism. These 
interactions are generally displayed in vitro, and may be 
difficult to establish evidence of advantages or 
disadvantages in vivo. Thus, the combination of 
trimethoprim and sulphamethoxazole (cotrimoxazole) can 
be shown to be synergistic in the test tube but it has been 
difficult to demonstrate clinical benefits, occasionally 
trimethoprim is now often used on its own to avoid the 
chance of toxic reactions to sulphonamides (Greenwood 
et al., 2002).  
Recently, the emergence of multi-drug resistant 
organisms has created a lot of concern in the medical 
field, hence there is a need to find an alternative to 
counter these multi-drug resistant organisms. In one 
study, honey was used at a concentration of 30 to 50% 
and it was found to be superior to cephaloridine, 
ampicillin, gentamicin, nitrofurantoin, nalidixic acid and 
cotrimoxazole in inhibiting growth of nine types of 
pathogenic organisms isolated from urine samples of 149 
patients with confirmed urinary tract infection (Ibrahim, 
1981; Karayil et al., 1998).  
In our investigation, two types of tests were done to 
evaluate the interaction between honey and gentamicin 
by testing for synergy and their killing activities. Synergy 
is known to exist between penicillin and streptomycin and 
between sulphamethoxazole and trimethoprim but that 
between honey and gentamicin has not been reported. 
The agar well diffusion method recommended by (Collee 
et al., 1996) was used in the synergy experiment. The 
method measures both the bacteriostatic and bactericidal 
interactions among antibiotics. It measures the combined 
interaction at concentrations that are normally below the 
minimum inhibitory concentration for each individual drug. 
This test can be quantified and we can establish whether 
drugs interact to give a response that is synergistic, 
additive, indifferent, or antagonistic (Koneman et al., 
1997). From the well diffusion method in our experiment, 
it was observed that the inhibition zone of gentamicin was 
bigger than that of honey and at the point where both 
zones meet there was no increase in zone size 
suggesting that no synergy existed between them. For 
synergy to exist, the combined zone size would be bigger 
than any zone produced by either alone.  
We have also investigated the reduction rate in viable 
counts of S. aureus using honey, gentamicin and honey 
with gentamicin (Al-Jabri et al., 2005a).  Honey  killed  34,  




Table 1. Zones of inhibition (mm) of the various dilutions of honey and four different milk 
samples. 
 
Zone of inhibition (mm) using different dilutions of milk/honey Substance 
100% 50% 25% 12.5% 6.3% 
Honey 42 33 27 22 <10 
Al-Marai Milk 20 11 00 00 00 
Al-Rawabi milk 00 00 00 00 00 
A’Safwa milk 00 00 00 00 00 
Sohar milk 18 <10 00 00 00 
     
 
         Table 2. The Staphylococcal aureus growth inhibition (%) by honey, milk and combinations of honey with milk. 
 
% of S. aureus growth reductions at different times (h) Substance 
0 1 2 4 6 8 10 12 14 16 18 20 22 24 
Honey alone (50%, v/v) 0 41 50 63 71 79 83 91 91 93 97 99 100 100 
Al-Marai milk 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Honey and Al-Marai milk 0 45 66 59 91 93 89 96 98 100 100 100 100 100 
Al-Rawabi milk 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Honey and Al-Rawabi milk 0 58 69 70 91 95 96 98 100 100 100 100 100 100 
         
Al-Rawabi milk and AL-Marai milk on their own did not demonstrate any killing activities, instead they actually promoted the 




84 and 100% of test organisms (S. aureus) within half an 
hour, in six hours and 24 hours, respectively, while 
gentamicin on its own killed 79% in 30 minutes and 
achieved 100% killing in six hours (Al-Jabri et al., 2005a). 
The combination of gentamicin and honey killed 90% 
within 30 minutes and 99% in six hours (Al-Jabri et al., 
2005a). Though the combination of honey and 
gentamicin showed some enhancement, the level of 
enhancement was not high enough (1000 fold) to 
describe it as synergy (Greenwood et al., 2002).  
Honey in combination with milk provides excellent 
nutritional value and it is recommended for use for 
children especially for the newborns as the main source 
of nutrition (Garanis-Papadatos and Katsas, 1999; Klain 
and Massimo, 1969).  Milk is generally accepted as 
having antimicrobial activities. Many bioactivities in milk 
are encrypted within the primary structure of milk 
proteins, requiring proteolysis for their release from 
precursors. Proteolysis may release these biogenic 
peptides during gastrointestinal transit or during food 
processing (Minervini et al., 2003; Meisel, 2001). These 
biological activities include opioid, agonist and antagonist 
peptides, hypotensive peptides which inhibit angiotensin-
I-converting enzyme (ACE), and mineral binding, 
immunomodulatory, antibacterial, and antithrombotic 
peptides (Minervini et al., 2003; Florisa et al., 2003; 
Meisel, 2001). 
Although more potent antibiotics are available, 
antimicrobial peptides show the advantages of being able 
to kill target cells rapidly and having a broad spectrum of 
activity, including activity for some of the more serious 
antibiotic-resistant pathogens in clinics. Since the rate of 
killing is higher than the rate of bacterial multiplication, 
this enhances the potential to overcome drug resistance. 
The main site of action of amphipathic or hydrophobic 
antimicrobial peptides is the cytoplasmic membrane 
where they tend to assemble to form channels. Some 
known antimicrobial fragments from bovine milk proteins 
are isracidin, casocidin-I, and lactoferricin. Bovine milk 
obtained by pepsin digestion was shown to be 
antimicrobial against Gram-positive and Gram-negative 
bacteria (Minervini et al., 2003; Florisa et al., 2003; 
Meisel, 2001). 
  The anti S. aureus activity of the screened bovine milk 
samples varied considerably; some had good activity 
while others did not have any. Our recent studies (Al-
Jabri et al., 2005b), confirms the previous observation 
that not all types of bovine milk possess antibacterial 
activity and that their antibacterial activities depended on 
the season of the year when they are collected. In one 
study we have demonstrated the killing activity of bovine 
milk and its mixture with honey (Al-Jabri et al., 2005b). 
Two milk samples were selected; one having an 
antibacterial activity by well diffusion method (Al-Marai), 
while the other did not (Al-Rawabi). When each of the 
milk was tested for antibacterial activity by growth 
reduction method of viable counts, it was observed that 
none of the milk samples killed the test organism but 
instead allowed the organism to grow (Tables 1 and 2). 
The reason why this happens is unknown but the 
availability of nutrients in the milk may be one reason.  
Most microorganisms need iron for growth and lactoferrin 
content of milk has the potential to inhibit the growth of 
bacteria and in most cases deprive them of iron. It has 
been observed that the effectiveness of the antibacterial 
activity of lactoferrin depends  on  the  iron   requirements   




of  the  organism,  the availability of exogenous iron and 
the degree of iron saturation of lactoferrin (Nagy et al., 
1976). The presence of exogenous iron ions in the milk 
may be responsible for lack of inhibition of growth of S. 
aureus by the individual milk samples. Our results agree 
with that of Diarra et al. (2002) who found that bovine 
milk containing lactoferrin when mixed with penicillin 
increased the inhibitory activity of penicillin and lactoferrin 
by 16 to 64 fold and reduced the growth rate of S. aureus 
strains tested. Though we used honey instead of 
penicillin and did not test the level of lactoferrin content of 
our milk, Al-Marai and Al-Rawabi milk used in our 
experiments are known to contain lactoferrin (Al-Abri, 
2003; Al-Jabri et al., 2005b). 
The killing rate of honey for S. aureus was shown to be 
40% in one hour, 82% in eight hours and 100% in twenty-
four hours. While the killing rate of Al-Marai and Al-Rwabi 
milk in separate combinations with honey was 92 and 
94%, respectively, in 8 hours. The result indicates that 
milk mixed with honey killed S. aureus faster than either 
alone. However, the improvement in this killing rate is 
better described as mild enhancement rather than 
synergy where the level of differences in antibacterial 
activity should be 1000 fold more than the individual 
activities of either milk or honey alone.  
From our experience, we have shown that not all milk 
samples possessed antibacterial activity against S. 
aureus (Table 1).  Two of four milk samples (Al-Rawabi 
and A’Safwa) failed to demonstrate any activity against S. 
aureus, rather allowed the organisms to grow (Al Hosni, 
2005).  At 2 hours, honey alone demonstrated 50% 
killing, while the combination of honey with either Al-
Marai or Al-Rawabi milk demonstrated 66% and 69% 
killing, respectively.  At 6 hours, honey killed 71% while 
the combination with either milk samples killed more than 
90% (Table 2). The combination of honey and milk 
showed higher growth reduction, enhancing the killing 
activity by approximately 20%. Honey alone requires 
more than 20 hours for killing all bacteria. However, when 
milk was combined with honey, 100% killing was 
achieved in 16 hours.  
The chemical composition of each honey sample is 
attributable to the nectar of each flower from where the 
bees produced honey. Honey is known to contain, 
phenol, fatty acids, lipids, amylases, ascorbic acid, 
peroxidases and fructose and has high osmolarity and 
low pH.  These elements acting alone or synergistically 
may contribute significantly to the antibacterial activity of 
honey (Oka et al., 1987, Wahdan, 1988). Although honey 
is known to have high antibacterial actions on different 
bacteria including those that are highly resistant to 
antibiotics (Nzeako and Hamdi, 2000), the exact mode of 
action of honey against many micro-organisms is still not 
clear at present. Although we do not know the exact 
mechanisms by which honey in combination with milk 
kills S. aureus faster than either alone,  it  is  possible  





milk and this may lead to the observed faster killing 
activity.  
This obviously requires more research in this important 
area.  In addition to the antibacterial activity of honey and 
milk, both have excellent nutritional values and would be 
an additional enhancer of immunity in aid to the 
treatments of bacterial infections. Honey in combination 
with milk may prolongs or improves the shelf life of each 
other. 
In conclusion, honey when mixed with an antibiotic had 
best killing effect within half an hour of exposure to 
bacteria than either an antibiotic or honey used alone. 
Honey in combination with bovine milk reduced the 
survival of bacteria faster than either honey or milk alone. 
Though honey on its own is used as medicine, antiseptic 
and food, we recommend that honey when used with milk 
may offer even faster killing rate of bacteria than either 
used alone.  Combining honey and milk may well prove 
to be an inexpensive way to fight infection and reduce the 
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